Dr. Sean Lavin, MD

Dr. Sean Lavin, MD

Strategic Advisory Board Member

Dr. Lavin is the CEO of Alpha Lavin Advisors, LLC an advisory firm founded in 2020 to help early-stage healthcare companies raise capital. He has held various roles, and has been employed mostly as a senior analyst covering medical devices, diagnostics, and digital health at BTIG, Lazard Capital Markets, and Oppenheimer and Company from 2006 until the end of 2019. Before that, Dr. Lavin graduated with a B.S. from the Massachusetts Institute of Technology and an M.D. from the Ohio State University College of Medicine. He completed two years of surgical residency training at Mt. Sinai Medical Center in Miami Beach where he treated patients in the emergency room, in trauma, and with the urologic, cardiac, plastic and reconstructive, transplant, vascular, thoracic, and general surgery teams.

Sean enjoys working with early stage companies. He uses his medical expertise and Wall Street experience to select innovative start-ups that often become very large multinational corporations that provide therapies to patients around the world. Since starting his Wall Street career in 2006, Sean has focused on minimally invasive devices that are able to treat patients with less associated morbidities and often lead to shorter hospital stays. These devices are almost always adopted as patients prefer the shorter recoveries and better outcomes and hospitals and payors prefer the decreased associated costs. Over the years, Sean has covered a number of companies in the assist device space including Abiomed (ABMD), Heartware (Previously HTWR – acquired by Medtronic), and Thoratec (Previously THOR – acquired by St Jude Medical (now Abbott). In many cases Sean was early to recommend investment in these companies.

Dr. Lavin will focus on financial advice, strategic alliances, and investor outreach. As a physician with training in surgery he will also be able to help MI-VAD source ideas on ways to help surgical implanters and patients around the world.